- Home
- RXT vs PHAR Comparison
RXT vs PHAR Comparison
Compare RXT & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- PHAR
- Stock Information
- Founded
- RXT 1998
- PHAR 1988
- Country
- RXT United States
- PHAR Netherlands
- Employees
- RXT N/A
- PHAR N/A
- Industry
- RXT EDP Services
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- RXT Technology
- PHAR Health Care
- Exchange
- RXT Nasdaq
- PHAR Nasdaq
- Market Cap
- RXT N/A
- PHAR 587.5M
- IPO Year
- RXT 2020
- PHAR N/A
- Fundamental
- Price
- RXT $1.44
- PHAR $10.01
- Analyst Decision
- RXT Sell
- PHAR Strong Buy
- Analyst Count
- RXT 2
- PHAR 3
- Target Price
- RXT $1.65
- PHAR $30.00
- AVG Volume (30 Days)
- RXT 701.5K
- PHAR 3.0K
- Earning Date
- RXT 05-08-2025
- PHAR 05-08-2025
- Dividend Yield
- RXT N/A
- PHAR N/A
- EPS Growth
- RXT N/A
- PHAR N/A
- EPS
- RXT N/A
- PHAR N/A
- Revenue
- RXT $2,737,100,000.00
- PHAR $23,805,200,000.00
- Revenue This Year
- RXT N/A
- PHAR $12.39
- Revenue Next Year
- RXT $1.73
- PHAR $9.84
- P/E Ratio
- RXT N/A
- PHAR N/A
- Revenue Growth
- RXT N/A
- PHAR 9113.93
- 52 Week Low
- RXT $1.24
- PHAR $6.65
- 52 Week High
- RXT $3.41
- PHAR $11.07
- Technical
- Relative Strength Index (RSI)
- RXT 45.91
- PHAR 71.58
- Support Level
- RXT $1.37
- PHAR $8.60
- Resistance Level
- RXT $1.45
- PHAR $9.40
- Average True Range (ATR)
- RXT 0.08
- PHAR 0.34
- MACD
- RXT 0.04
- PHAR 0.15
- Stochastic Oscillator
- RXT 65.52
- PHAR 87.89
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.